MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CANN, J. R.
Right arrow Articles by HINMAN, N. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CANN, J. R.
Right arrow Articles by HINMAN, N. D.

Molecular Pharmacology, Vol 11, 256-267, Copyright © 1975 by the American Society for Pharmacology and Experimental Therapeutics

Interaction of Chlorpromazine with Brain Microtubule Subunit Protein

JOHN R. CANN 1 and NORMAN D. HINMAN 1

1 Department of Biophysics and Genetics, University of Colorado Medical Center, Denver, Colorado 80220

Chlorpromazine at concentrations which approximate apparent physiological concentrations interacts reversibly with brain microtubule subunit protein in vitro and, in so doing, inhibits the rate of reassembly of microtubules and the binding of colchicine by the protein. It also causes dissassembly of microtubules formed in the absence of the drug. These results appear to provide a molecular explanation for inhibition by chlorpromazine of fast axonal transport of proteins in vitro in frog sciatic nerve, and provide a fresh clue as to the primary mechanism for the psychotropic effect of this drug.

Submitted on November 5, 1974







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1975 by the American Society for Pharmacology and Experimental Therapeutics